 |
PDBsum entry 1zlg
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hormone/growth factor
|
PDB id
|
|
|
|
1zlg
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
* C-alpha coords only
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hormone/growth factor
|
 |
|
Title:
|
 |
Solution structure of the extracellular matrix protein anosmin-1
|
|
Structure:
|
 |
Anosmin 1. Chain: a. Synonym: kallmann syndrome protein, adhesion molecule-like x-linked. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: kal1, admlx, kal, kalig1. Expressed in: drosophila melanogaster. Expression_system_taxid: 7227.
|
|
Authors:
|
 |
Y.Hu,Z.Sun,J.T.Eaton,P.M.Bouloux,S.J.Perkins
|
Key ref:
|
 |
Y.Hu
et al.
(2005).
Extended and flexible domain solution structure of the extracellular matrix protein anosmin-1 by X-ray scattering, analytical ultracentrifugation and constrained modelling.
J Mol Biol,
350,
553-570.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
06-May-05
|
Release date:
|
09-May-06
|
|
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P23352
(KALM_HUMAN) -
Anosmin-1 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
680 a.a.
680 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
350:553-570
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
Extended and flexible domain solution structure of the extracellular matrix protein anosmin-1 by X-ray scattering, analytical ultracentrifugation and constrained modelling.
|
|
Y.Hu,
Z.Sun,
J.T.Eaton,
P.M.Bouloux,
S.J.Perkins.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Kallmann's syndrome corresponds to a loss of sense of smell and
hypogonadotrophic hypogonadism. Defects in anosmin-1 result in the X-linked
inherited form of Kallmann's syndrome. Anosmin-1 is an extracellular matrix
protein comprised of an N-terminal, cysteine-rich (Cys-box) domain and a whey
acidic protein-like (WAP) domain, followed by four fibronectin type III (FnIII)
domains. The solution structures of recombinant proteins containing the first
three domains (PIWF1) and all six domains (PIWF4) were determined by X-ray
scattering and analytical ultracentrifugation. Guinier analyses showed that
PIWF1 and PIWF4 have different radii of gyration (R(G)) values of 3.1 nm and 6.7
nm, respectively, but similar cross-sectional radii of gyration (R(XS)) values
of 1.5 nm and 1.9 nm, respectively. Distance distribution functions showed that
the maximum lengths of PIWF1 and PIWF4 were 11 nm and 23 nm, respectively.
Analytical ultracentrifugation gave sedimentation coefficients of 2.52 S and
3.55 S for PIWF1 and PIWF4, respectively. The interpretation of the scattering
data by constrained modelling requires homology models for all six domains in
anosmin-1. While models were already available for the WAP and FnIII domains,
searches suggested the Cys-box domain may resemble the cysteine-rich region of
the insulin-like growth factor receptor. Automated constrained molecular
modelling based on joining the anosmin-1 domains with structurally randomised
linkers resulted in 10,000 models for anosmin-1. A trial-and-error search showed
that about 0.1-1.4% of these models fitted the X-ray data. The best models
showed that the three domains and six domains in PIWF1 and PIWF4, respectively,
were extended. The inter-domain linkers in anosmin-1 could not all be extended
at the same time, and there was evidence for inter-domain flexibility. Models
with folded-back domain arrangements do not fit the data. These solution
structures account for the known biological function of anosmin-1, in particular
its ability to interact with its three macromolecular ligands.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 4.
Figure 4. Distance distribution functions P(r) for (a)
PIWF1 and (b) PIWF4. The maximum of the P(r) curve is denoted by
M, the most frequently occurring distance within PIWF1 and
PIWF4. The maximum dimension of PIWF1 and PIWF4 is denoted by L
where the P(r) curve intersects P(r)=0.
|
 |
Figure 6.
Figure 6. Sedimentation velocity fits for PIWF1 and PIWF4.
Ten scans recorded at eight minute intervals were recorded using
(a) absorbance at 280 nm and (b) interference optics. In (a) and
(b), a rotor speed of 35,000 rpm was used for PIWF1 at 1.12
mg/ml. In (c), a rotor speed of 25,000 rpm was used for PIWF4 at
0.32 mg/ml. All 200 scans were used in the fit, but only every
tenth scan is shown for clarity. Analysis gave s^o[20,w] values
of (a) and (b) 2.46 S and 2.32 S for PIWF1 from the DCDT+
program at the peak position of the g(s*) distributions
(arrowed), and (c) 3.80 S for PIWF4 from the SEDFIT program. The
circles represent the experimental data and the continuous lines
represent the fits to these.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2005,
350,
553-570)
copyright 2005.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
Y.Hu,
and
P.M.Bouloux
(2010).
Novel insights in FGFR1 regulation: lessons from Kallmann syndrome.
|
| |
Trends Endocrinol Metab,
21,
385-393.
|
 |
|
|
|
|
 |
Y.Hu,
S.E.Guimond,
P.Travers,
S.Cadman,
E.Hohenester,
J.E.Turnbull,
S.H.Kim,
and
P.M.Bouloux
(2009).
Novel mechanisms of fibroblast growth factor receptor 1 regulation by extracellular matrix protein anosmin-1.
|
| |
J Biol Chem,
284,
29905-29920.
|
 |
|
|
|
|
 |
C.Neylon
(2008).
Small angle neutron and X-ray scattering in structural biology: recent examples from the literature.
|
| |
Eur Biophys J,
37,
531-541.
|
 |
|
|
|
|
 |
A.Bonner,
C.Perrier,
B.Corthésy,
and
S.J.Perkins
(2007).
Solution structure of human secretory component and implications for biological function.
|
| |
J Biol Chem,
282,
16969-16980.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.B.Trarbach,
L.G.Silveira,
and
A.C.Latronico
(2007).
Genetic insights into human isolated gonadotropin deficiency.
|
| |
Pituitary,
10,
381-391.
|
 |
|
|
|
|
 |
C.Dodé,
L.Teixeira,
J.Levilliers,
C.Fouveaut,
P.Bouchard,
M.L.Kottler,
J.Lespinasse,
A.Lienhardt-Roussie,
M.Mathieu,
A.Moerman,
G.Morgan,
A.Murat,
J.E.Toublanc,
S.Wolczynski,
M.Delpech,
C.Petit,
J.Young,
and
J.P.Hardelin
(2006).
Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2.
|
| |
PLoS Genet,
2,
e175.
|
 |
|
|
|
|
 |
P.S.Tsai,
and
J.C.Gill
(2006).
Mechanisms of disease: Insights into X-linked and autosomal-dominant Kallmann syndrome.
|
| |
Nat Clin Pract Endocrinol Metab,
2,
160-171.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |